Home / Neuroscience
Neuroscience
| 2 min read
The therapy crosses the blood-brain barrier after peripheral injection and delivers behavioral improvements that last up to seven days.
| 4 min read
FDA rejections and safety concerns, a once-monthly HIV PrEP pill, developments in neuroscience drug development, and more led the news this week.
| 3 min read
Boosting UBA5 gene production normalized neuronal activity in the first organoid model of the developmental and epileptic encephalopathy.
| 4 min read
Discover how ubrogepant provides migraine relief during the prodrome phase, easing symptoms before headaches fully develop.
| 10 min read
Learn about the latest advances in age-related macular degeneration (AMD) treatment, including a new drug that targets beta-amyloid to help prevent blindness and vision loss.
| 3 min read
The FDA approved Medtronic’s adaptive deep brain stimulation system, which delivers electrical stimulation in real time based on the brain’s state.
| 3 min read
New research shows a promising treatment for chronic back pain by targeting undying cells. Learn how senolytic drugs could revolutionize pain management.
Available on Demand
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
| 6 min read
QurAlis researchers have developed QRL-101, a new drug candidate that targets overactive neurons to prevent cell death in ALS.
| 4 min read
Biotech and pharma leaders reveal the neurological therapies in development that they’re most excited about.
| 3 min read
A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.
| 4 min read
In a Phase 2b trial, Khondrion’s sonlicromanol led to significant health benefits for patients with mitochondrial disease linked to a common mutation.
